 |
|
DES (diethylstilbestrol), a synthetic estrogen, was prescribed to millions of pregnant women in the United States from 1938 to 1971. Although DES is no longer prescribed to pregnant women in the United States due to its health effects, DES exposure continues to affect many lives.
DES Update Home: For Consumers, Health Care Providers, and DES Update Partners
The Centers for Disease Control and Prevention's DES Update, a comprehensive information resource for consumers and health
care providers on diethylstilbestrol (DES) and DES-related health effects.
DES: Questions and Answers
A fact sheet about DES (a synthetic form of estrogen) and the health problems of children who were exposed to DES while in the womb. National Cancer Institute Fact Sheet 3.4
Clinician Information: Identification and Management of Persons Exposed to DES (Diethylstilbestrol)
Information about women prescribed DES, men exposed in utero, and women exposed in utero.
DES Research Update 1999: Current Knowledge, Future Directions
Proceedings from the DES Research Update 1999: Current Knowledge, Future Directions conference, July 19-20, 1999, sponsored the National Cancer Institute, National Institute of Environmental Health Sciences, Office of Research on Women's Health, and Centers for Disease Control and Prevention.
No Increased Risk for Most Cancers Yet Observed in Daughters of Women Exposed to DES in the 1940s and 1950s
The first systematic follow-up study of a large group of women whose mothers
were given the synthetic estrogen diethylstilbestrol (DES) during pregnancy in
the 1940s and 1950s found no increase in any type of cancer except for clear
cell adenocarcinoma of the vagina and cervix in women under age 30.
National Toxicology Program: Diethylstilbestrol
Information about DES from the National Toxicology Program (NTP) Eleventh Report on Carcinogens.
|
|
|
